Stay updated on Asciminib Combo with Imatinib in CML-CP Clinical Trial
Sign up to get notified when there's something new on the Asciminib Combo with Imatinib in CML-CP Clinical Trial page.

Latest updates to the Asciminib Combo with Imatinib in CML-CP Clinical Trial page
- Check6 days agoChange DetectedThe page shows a new Revision: v3.6.3, replacing the previous v3.6.2. This indicates a small update to the study record rather than changes to the study content or eligibility.SummaryDifference0.0%

- Check14 days agoChange DetectedThe page now displays an updated revision tag (v3.6.2) replacing the previous v3.6.0, indicating a minor update to the page's version/metadata rather than changing core study information.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedNew navigation items and help sections were added to the Study Details page, including How to Read a Study Record, Common Questions, How to Join a Study, and an updated Intervention/Treatment section. The previous label 'Intervention / Treatment' was replaced with 'Intervention/Treatment', and the site revision note updated to Revision: v3.6.0.SummaryDifference0.3%

- Check35 days agoChange DetectedThe page's revision label now shows v3.5.5, replacing v3.5.4. This reflects a minor update to the page's revision metadata rather than content changes.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page’s revision label has been updated from v3.5.3 to v3.5.4, indicating a minor update to the documentation/versioning of the study page. This reflects an administrative update rather than any change to the trial data or details.SummaryDifference0.0%

- Check71 days agoChange DetectedTaoyuan District, Taiwan, 33305 was replaced with Taoyuan, Taiwan, 33305 in the Locations section. This updates the listed site to reflect the correct municipality.SummaryDifference0.0%

Stay in the know with updates to Asciminib Combo with Imatinib in CML-CP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Asciminib Combo with Imatinib in CML-CP Clinical Trial page.